You are here

  • Home
  • Archive
  • Volume 11, Issue 3
  • ANalgesic Efficacy and safety of MOrphiNe versus methoxyflurane in patients with acute myocardial infarction: the rationale and design of the ANEMON-SIRIO 3 study: a multicentre, open-label, phase II, randomised clinical trial

Article metrics

Article menu

Download PDFPDF

XML
Cardiovascular medicine
Protocol
ANalgesic Efficacy and safety of MOrphiNe versus methoxyflurane in patients with acute myocardial infarction: the rationale and design of the ANEMON-SIRIO 3 study: a multicentre, open-label, phase II, randomised clinical trial

 

Online download statistics by month:

Online download statistics by month: March 2021 to April 2024

AbstractFullPdf
Mar 202115514280
Apr 20211179576
May 2021140136102
Jun 202110911045
Jul 202116215839
Aug 2021908842
Sep 2021848135
Oct 2021736151
Nov 2021433927
Dec 2021352733
Jan 2022515632
Feb 2022383726
Mar 2022444029
Apr 2022594738
May 2022646460
Jun 2022404325
Jul 2022363522
Aug 2022605322
Sep 2022524933
Oct 2022433824
Nov 2022444225
Dec 202228278
Jan 2023454318
Feb 2023424028
Mar 202312312223
Apr 2023484832
May 2023414218
Jun 2023504610
Jul 2023474517
Aug 20231009223
Sep 202315915526
Oct 20231059725
Nov 202313512822
Dec 2023746932
Jan 2024746423
Feb 2024867617
Mar 2024817174
Apr 2024696732
Total284626731294